Clinical Care/Education/Nutrition
O R I G I N A L A R T I C L E
A Low-Fat Vegan Diet Improves Glycemic
Control and Cardiovascular Risk Factors in
a Randomized Clinical Trial in Individuals
With Type 2 Diabetes
NEALD.BARNARD,MD1,2 BRENTJASTER,MD2 usedintheabsenceofexercise,wasasso-
JOSHUACOHEN,MD1 KIMSEIDL,MS,RD2 ciated with increased insulin sensitivity
DAVIDJ.A.JENKINS,MD,PHD3 AMBERA.GREEN,RD2 andreducedbodyweightinnondiabetic
GABRIELLETURNER-MCGRIEVY,MS,RD4 STANLEYTALPERS,MD1
overweightwomen(4).
LISEGLOEDE,RD,CDE5
We therefore conducted a random-
ized controlled trial of a vegan diet with
exerciseheldconstanttotestthehypoth-
OBJECTIVE— We sought to investigate whether a low-fat vegan diet improves glycemic esisthat,inindividualswithtype2diabe-
controlandcardiovascularriskfactorsinindividualswithtype2diabetes. tes, a low-fat plant-based diet improves
glycemic, plasma lipid, and weight con-
RESEARCHDESIGNANDMETHODS— Individualswithtype2diabetes(n(cid:1)99)
trol compared with a diet based on cur-
were randomly assigned to a low-fat vegan diet (n (cid:1) 49) or a diet following the American
DiabetesAssociation(ADA)guidelines(n(cid:1)50).Participantswereevaluatedatbaselineand22 rentADAguidelines.
weeks.
RESEARCH DESIGN AND
RESULTS— Forty-threepercent(21of49)ofthevegangroupand26%(13of50)oftheADA METHODS— Individualswithtype2
groupparticipantsreduceddiabetesmedications.Includingallparticipants,HbA (A1C)de- diabetes,definedbyafastingplasmaglu-
1c
creased 0.96 percentage points in the vegan group and 0.56 points in the ADA group (P (cid:1) cose concentration (cid:3)6.9 mmol/l on two
0.089). Excluding those who changed medications, A1C fell 1.23 points in the vegan group
occasions or a prior diagnosis of type 2
comparedwith0.38pointsintheADAgroup(P(cid:1)0.01).Bodyweightdecreased6.5kginthe
diabetes with the use of hypoglycemic
v cheg aa nn gegr (o ru (cid:1)pa 0n .d 513 ,.1 nkg (cid:1)in 5t 7h ,e PAD (cid:2)A 0g .r 0o 0u 0p 1( )P
.
(cid:2) Am0 o.0 n0 g1 t) h. oB so edy ww hoeig dh idtc nh oan tg ce hc ao nr gr eel la it pe id d-w loit wh eA ri1 nC
g
medications for (cid:1)6 months, were re-
medications,LDLcholesterolfell21.2%inthevegangroupand10.7%intheADAgroup(P(cid:1) cruited through newspaper advertise-
0.02).Afteradjustmentforbaselinevalues,urinaryalbuminreductionsweregreaterinthevegan ments in the Washington, DC, area on
group(15.9mg/24h)thanintheADAgroup(10.9mg/24h)(P(cid:1)0.013). two occasions (October 2003 through
December 2003 and October 2004
CONCLUSIONS— Bothalow-fatvegandietandadietbasedonADAguidelinesimproved throughDecember2004)tocompletethe
glycemicandlipidcontrolintype2diabeticpatients.Theseimprovementsweregreaterwitha study from January 2004 through June
low-fatvegandiet. 2004 and January 2005 through June
2005, respectively. Exclusion criteria
DiabetesCare29:1777–1783,2006 were an HbA (A1C) (cid:2)6.5 or (cid:3)10.5%,
1c
useofinsulinfor(cid:3)5years,currentsmok-
Diabetes prevalence is relatively low fects.Ina12-weekpilottrialofalow-fat ing, alcohol or drug abuse, pregnancy,
amongindividualsfollowingplant- vegandietinindividualswithtype2dia- unstable medical status, and current use
based and vegetarian diets, and betes,conductedwithoutincreasedexer- ofalow-fatvegetariandiet.Theprotocol
clinicaltrialsusingsuchdietshaveshown cise,fastingserumglucoseconcentration wasapprovedbytheGeorgeWashington
improvements in glycemic control and dropped28%comparedwith12%inthe UniversityInstitutionalReviewBoard.All
cardiovascularhealth(1,2).Mostofthese control group following a diet based on participants gave written informed
trials have also included exercise, thus American Diabetes Association (ADA) consent.
making it impossible to isolate diet ef- guidelines(P(cid:2)0.05)(3).Asimilardiet, A1Cwasassayedusingaffinitychro-
matography on an Abbott IMx analyzer
● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●
(5). Volunteers were ranked in order of
Fromthe1DepartmentofMedicine,GeorgeWashingtonUniversitySchoolofMedicine,Washington,DC;
A1C concentrations and randomly as-
the2PhysiciansCommitteeforResponsibleMedicine,Washington,DC;the3DepartmentofNutritional
signed in sequential pairs, using a ran-
Sciences,FacultyofMedicine,UniversityofToronto,andtheClinicalNutritionandRiskFactorModification
Center,St.Michael’sHospital,Toronto,Canada;the4DepartmentofNutrition,SchoolofPublicHealth, dom-numbertable,toalow-fatvegandiet
UniversityofNorthCarolina,ChapelHill,NorthCarolina;and5Privatepractice,Arlington,Virginia. oradietfollowingthe2003ADAguide-
AddresscorrespondenceandreprintrequeststoNealD.Barnard,MD,5100WisconsinAve.,Suite400, lines (6) for 22 weeks. Because assign-
Washington,DC20016.E-mail:nbarnard@pcrm.org.
mentwasdonesimultaneously,allocation
Receivedforpublication20March2006andacceptedinrevisedform15May2006.
concealmentwasunnecessary.
Abbreviations:ADA,AmericanDiabetesAssociation.
AtableelsewhereinthisissueshowsconventionalandSyste`meInternational(SI)unitsandconversion
Thevegandiet((cid:4)10%ofenergyfrom
factorsformanysubstances. fat,15%protein,and75%carbohydrate)
DOI:10.2337/dc06-0606.Clinicaltrialreg.no.NCT00276939,clinicaltrials.gov. consistedofvegetables,fruits,grains,and
©2006bytheAmericanDiabetesAssociation.
legumes.Participantswereaskedtoavoid
Thecostsofpublicationofthisarticleweredefrayedinpartbythepaymentofpagecharges.Thisarticlemustthereforebehereby
marked“advertisement”inaccordancewith18U.S.C.Section1734solelytoindicatethisfact. animal products and added fats and to
DIABETESCARE,VOLUME29,NUMBER8,AUGUST2006 1777
©
Low-fatvegandietandtype2diabetes
favorlow–glycemicindexfoods,suchas 24-h recalls or incidentally at any point, ence was measured at the maximal pro-
beansandgreenvegetables.Portionsizes, assaturatedfat(cid:2)5%andtotalfat(cid:2)25% trusionofthebuttocks.
energy intake, and carbohydrate intake ofenergy,andasaveragedailycholesterol Blood pressure was measured after
wereunrestricted. intake(cid:2)50mgon3-daydietaryrecords participants had rested in a seated posi-
TheADAdiet(15–20%protein,(cid:2)7% at 22 weeks. Adherence for the ADA tion for 5 min using a digital monitor
saturated fat, 60–70% carbohydrate and groupwasdefinedasaveragedailyenergy (Omron HEM-711) and a standard cuff
monounsaturated fats, and cholesterol intake on the 22-week 3-day dietary maintainedattheleveloftheheart.Three
(cid:2)200mg/day)wasindividualized,based records being no more than 200 kcal in measurementsweretakenat2-mininter-
onbodyweightandplasmalipidconcen- excessoftheintakeprescribedbythereg- vals; the first measurement was disre-
trations(6).ADAgroupparticipantswith istered dietitian and saturated fat (cid:2)10% garded,andameanwascalculatedforthe
a BMI(cid:3) 25 kg/m2 (all but three ADA of energy. Individuals who attended remainingtwovalues.
group participants) were prescribed en- fewer than 10 of the 22 weekly sessions
ergyintakedeficitsof500–1,000kcal. werealsoconsiderednonadherentonei- Statisticalanalyses
Nomealswereprovided.Tomeetthe therdiet. To have an 80% chance of detecting a
vitamin B needs of the vegan group Participants were asked to continue 1.5–percentage point between-group
12
while maintaining the same intervention their preexisting medication regimens, A1Cdifferenceassignificant(atthetwo-
in the ADA group, all participants were exceptwhenfastingplasmaglucosedeter- sided 5% level), with an assumed SD of
providedavitaminB supplement(100 minationsfellbelow4.4mmol/lorhypo- 1.9%andalosstofollow-upof26%,34
12
(cid:5)g)tobetakeneveryotherday.Forboth glycemic symptoms were accompanied participantswererequiredpergroup.An
groups,alcoholicbeverageswerelimited by a capillary glucose reading (cid:2)3.6 interim analysis indicated group differ-
tooneperdayforwomenandtwoperday mmol/l. In such cases, medications were encesof0.8%withanSDof1.3%;there-
for men. Participants were asked not to reduced for participant safety by a study fore, a revised power analysis was
altertheirexercisehabitsduringtheinter- endocrinologist, who remained blind to conducted.Tohavean80%chanceofde-
ventionperiod. group assignment, following an estab- tecting a 0.8% difference as significant
Each participant met for 1 h with a lishedprotocol. withanSDof1.3%andlosstofollow-up
registereddietitianexperiencedintheuse Laboratorymeasurementsweremade of 33%, an additional 15 participants
oftheassigneddiettoestablishanappro- after a 12-h fast by technicians blind to wererequiredpergroup.
priate diet plan. Thereafter, participants groupassignment.A1C(theprimaryend Between-subject t tests were calcu-
attendedweekly1-hmeetingsoftheiras- point)wasassayedat0,11,and22weeks, lated for each measure to determine
signed groups for nutrition and cooking as described above. All other measures whether the changes associated with the
instructionconductedbyaphysicianand were assessed at baseline and 22 weeks, interventiondietweregreaterthanthose
aregistereddietitianand/oracookingin- exceptasnoted.Plasmaglucosewasmea- associated with the control diet. Within
structor.Sessionsforthetwogroupswere suredbytheglucoseoxidasemethodus- eachdietgroup,pairedcomparisonttests
similar in duration and content, except inganAbbottSpectrumanalyzer(Abbott were calculated to test whether the
withregardtodietarydetails.Grouplead- Park, IL) (8). Plasma cholesterol and tri- changefrombaselineto22weekswassig-
erswereinstructedtomakenocomment glyceride concentrations were measured nificantly different from zero. The pri-
favoringeitherdietovertheother. by enzymatic methods using an Abbott maryanalysisofthemainendpointwas
Atweeks4,8,13,and20,aregistered Spectrum analyzer (9,10). HDL choles- intentiontotreatandincludedallpartic-
dietitian made unannounced telephone terol was measured after double precipi- ipants.Becausemedicationchangesinflu-
calls to each participant to administer a tationwithdextranandMgCl (11).LDL ence the dependent measures,
2
24-h diet recall. These recalls were not cholesterol was estimated using the exploratory analyses were performed for
statisticallyanalyzed,butallowedthein- Friedewaldequation(12).Inindividuals the subgroup whose medications re-
vestigators to check for poor adherence whoseplasmatriglycerideconcentrations mainedconstant.An(cid:6)of0.05wasused
andprovideadditionaldietarycounseling exceeded400mg/dl,LDLcholesterolwas forallstatisticaltests,withnoadjustment
asneeded. measured directly by precipitation and formultiplecomparisons.
In addition, a 3-day dietary record magnetic separation (LipiDirect; Poly- Regressionanalysesassessedwhether
was completed by each participant at medco,CortlandtManor,NY).Non-HDL the diet group effects on A1C and body
weeks0,11,and22,on2weekdaysand1 cholesterol concentration was calculated weightweresignificant,whilecontrolling
weekendday,usingafoodscale,afterpar- as the difference between total and HDL forbaselinevalues,andwhetherthediet
ticipantshadcompleteda3-daypractice cholesterol. Urinary albumin was mea- groupeffectonA1Cwassignificant,while
record. Using the Nutrition Data System sured on 24-h samples using an anionic controllingforbaselineA1Candchanges
for Research software version 5.0 (Food dye–bindingassay(13). inbodyweight.Pearsoncorrelationswere
and Nutrient Database 35 [released May Physical activity was assessed over a calculated for the relationship between
2004]; Nutrition Coordinating Center, 3-day period by pedometer (Omron HJ- A1Cchangeandweightchange.
University of Minnesota, Minneapolis, 112)andwiththeBouchard3-DayPhys- Aninterimanalysiswasperformedaf-
MN)(7),aregistereddietitiancertifiedby ical Activity Record (14). Body weight ter week 11 to assess whether benefits
the Nutrition Coordinating Center ana- was determined at 0, 11, and 22 weeks, or adverse outcomes were statistically
lyzed all 3-day dietary records and diet before breakfast while participants wore unusual.
recalls. For purposes of statistical analy- hospitalgowns,usingadigitalscaleaccu-
sis,dietaryadherenceforthevegangroup rate to 0.1 kg. Waist circumference was RESULTS— Of 1,049 individuals
wasdefinedastheabsenceofmeat,poul- measuredwithatapemeasureplaced2.5 screenedbytelephone,99metparticipa-
try,fish,dairy,oreggintakereportedon cm above the umbilicus. Hip circumfer- tioncriteriaandwererandomlyassigned
1778 DIABETESCARE,VOLUME29,NUMBER8,AUGUST2006
©
BarnardandAssociates
Table1—Baselinedemographicandclinicalvariables g/day,P(cid:2)0.0001;ADA23(cid:7)12to14(cid:7)
6g/day,P(cid:2)0.0001[between-groupP(cid:2)
0.001]) and cholesterol (vegan 291 (cid:7)
Vegangroup ADAgroup Pvalue
223to24(cid:7)57mg/day,P(cid:2)0.0001;ADA
n 49 50 317 (cid:7) 200 to 189 (cid:7) 89 mg/day, P (cid:2)
Age(years) 56.7(35–82) 54.6(27–80) 0.29 0.0001[between-groupP(cid:1)0.002]).Fi-
Sex 0.26 berincreasedonlyamongvegans(18.8(cid:7)
Male 22(45) 17(34) 6.4 to 36.3 (cid:7) 13.3 g/day, P (cid:2) 0.0001;
Female 27(55) 33(66) ADA19.5(cid:7)6.9to19.0(cid:7)7.9g/day,P(cid:1)
Race,ethnicity 0.71* 0.73[between-groupP(cid:2)0.001]).
Black,non-Hispanic 22(45) 22(44) Pedometerreadingsandself-reported
White,non-Hispanic 21(43) 22(44) energy expenditure revealed no signifi-
White,Hispanic 4(8) 2(4) cant between-group differences. Group-
Asian,non-Hispanic 2(4) 4(8) specific dietary adherence criteria were
Maritalstatus 0.08 met by 67% (33 of 49) of vegan group
Notmarried 20(41) 26(52) participants and 44% (22 of 50) of ADA
Married 29(59) 24(48) group participants. During the interven-
Education 0.69 tion period, 43% (21 of 49) of vegan
Highschool,partialorgraduate 6(12) 3(6) groupparticipantsand26%(13of50)of
College,partialorgraduate 26(53) 25(50) ADAgroupparticipantsreducedtheirdi-
Graduatedegree 17(35) 22(44) abetes medications, mainly as necessi-
Occupation 0.04 tated by hypoglycemia, while 8% (4 of
Serviceoccupation 3(6) 7(14) 49) of vegans and 8% (4 of 50) of ADA
Technical,sales,administrative 16(33) 18(36) participants increased medications with-
Professionalormanagerial 15(31) 21(42) outinvestigators’authorization.
Retired 15(31) 4(8) A1Cfell0.96percentagepoints(P(cid:2)
Oninsulin 11(22) 5(10) 0.09 0.0001)inthevegangroupand0.56per-
Onmetformin 34(69) 39(78) 0.33 centagepoints(P(cid:1)0.0009)intheADA
Onsulfonylurea 25(51) 29(58) 0.49 group (between-group P (cid:1) 0.089; base-
Onthiazolidinedione 16(33) 15(30) 0.78 line-adjustedP(cid:1)0.091;Table2andFig.
Onotherdiabetesmedications 1(2) 2(4) 0.57 1). Among participants whose diabetes
Onbloodpressuremedications 31(63) 38(76) 0.17 medications remained unchanged
Onlipid-loweringmedications 27(55) 27(54) 0.88 throughout (n (cid:1) 24 vegan and n (cid:1) 33
Historyofeyeinvolvement 9(18) 10(20) 0.82 ADA), A1C fell 1.23 points in the vegan
Historyofrenalinvolvement 6(12) 4(8) 0.48 groupand0.38pointsintheADAgroup
Historyofneuropathy 18(37) 24(48) 0.25 (P(cid:1)0.01;baseline-adjustedP(cid:1)0.007).
MeanBMI(kg/m2) 33.9 35.9 0.18 Subanalyseswereconductedtoassessthe
(cid:2)25kg/m2 5(10) 2(4) effects of dietary adherence. For those
25–29.9kg/m2 14(29) 5(10) whometadherencecriteria(n(cid:1)33vegan
(cid:1)30kg/m2 30(61) 43(86) andn(cid:1)22ADA),theA1Cchangeswere
Dataaremean(range)orn(%)unlessotherwiseindicated.Pvaluesrefertottestforcontinuousvariablesand (cid:8)1.20% for the vegan group and
(cid:9)2forcategoricalvariables.*Pvaluecalculatedforracedistribution;forethnicity(Hispanicvs.non-His- (cid:8)0.88% for the ADA group (P (cid:1) 0.31).
panic),P(cid:1)0.39.
For those who were both adherent and
medicationstable(n(cid:1)17veganandn(cid:1)
to the vegan (n (cid:1) 49) or ADA (n (cid:1) 50) ducedenergyintake(vegan1,759(cid:7)468 12ADA),A1Cchangeswere(cid:8)1.48%for
groups. The reasons for exclusion were to 1,425 (cid:7) 427 kcal/day, P (cid:2) 0.0001; thevegangroupand(cid:8)0.81%fortheADA
A1C values outside the required range ADA1,846(cid:7)597to1,391(cid:7)382kcal/ group(P(cid:1)0.15).
(n(cid:1)201),failuretomeetotherparticipa- day, P (cid:2) 0.0001 [between-group P (cid:1) To test whether the effect of diet on
tioncriteria(n(cid:1)279),inabilitytoattend 0.22])andproteinintake(vegan77(cid:7)27 A1C was mediated by body weight
scheduledmeetings(n(cid:1)187),failureto to51(cid:7)16g/day,P(cid:2)0.0001;ADA85(cid:7) changes, a regression model was con-
keep interview appointment (n (cid:1) 153), 27to73(cid:7)23g/day,P(cid:1)0.002[between structed,includingbaselineA1C,weight
reluctance to change diet (n (cid:1) 72), and group P (cid:1) 0.01]). Carbohydrate intake change, and diet group as predictors of
otherorunspecified(n(cid:1)58).Thepartic- increasedinthevegangroupfrom205(cid:7) A1C change, among those whose hypo-
ipants’ demographic and clinical charac- 69 to 251 (cid:7) 70 g/day (P (cid:2) 0.0001) but glycemicmedicationsremainedconstant.
teristics(Table1)weresimilartothoseof fellintheADAgroupfrom213(cid:7)70to Inthismodel,theeffectofdietgroupwas
individuals with type 2 diabetes in the 165 (cid:7) 51 g/day (P (cid:2) 0.0001 [between- nolongersignificant(P(cid:1)0.23).Control-
Washington, DC, area. All participants groupP(cid:2)0.001]). ling for diet group and for baseline A1C
completed laboratory assessments at 22 Fat intake fell in both groups (vegan scores, weight change was significantly
weeks. 72(cid:7)28to30(cid:7)19g/day,P(cid:2)0.0001; associated with A1C change; each kilo-
Three vegan participants and eight ADA 73 (cid:7) 35 to 52 (cid:7) 21 g/day, P (cid:2) gramofweightlosswasassociatedwitha
ADA participants failed to complete 22- 0.0001 [between-group P (cid:1) 0.002]), as 0.12% drop in A1C. For the subgroup
week dietary records. Both groups re- didsaturatedfat(vegan23(cid:7)10to6(cid:7)4 thatdidnotchangediabetesmedications,
DIABETESCARE,VOLUME29,NUMBER8,AUGUST2006 1779
©
serusaemlacinilcnostceffeteiD—2elbaT
)detonsatpecxe,05(cid:1)n(puorgADA
)detonsatpecxe,94(cid:1)n(puorgnageV
eulavP
ezistceffE
egnahC
skeew22
enilesaB
egnahC
skeew22
enilesaB
selbairavcimecylgdnacirtemoporhtnA
stnapicitrapllA
90.0
)1.0ot9.0(cid:8)(4.0(cid:8)
†1.1(cid:7)6.0(cid:8)
0.1(cid:7)4.7
0.1(cid:7)9.7
*2.1(cid:7)0.1(cid:8)
0.1(cid:7)1.7
1.1(cid:7)0.8
)%(C1A
29.0
)89.0ot80.1(cid:8)(50.0(cid:8)
*84.2(cid:7)29.1
19.1(cid:7)89.6
62.2(cid:7)09.8
*86.2(cid:7)79.1(cid:8)
79.1(cid:7)11.7
59.2(cid:7)80.9
)l/lomm(esoculgamsalpgnitsaF
29.0
)6.71ot5.91(cid:8)(9.0(cid:8)
*7.44(cid:7)6.43(cid:8)
4.43(cid:7)8.521
7.04(cid:7)4.061
*3.84(cid:7)5.53(cid:8)
5.53(cid:7)0.821
2.35(cid:7)5.361
)ld/gm(esoculgamsalpgnitsaF
80.0
)2.0ot3.3(cid:8)(6.1(cid:8)
*4.4(cid:7)3.4(cid:8)
9.02(cid:7)0.59
0.12(cid:7)3.99
*4.4(cid:7)8.5(cid:8)
4.22(cid:7)1.19
9.22(cid:7)0.79
)gk(thgieW
80.0
)1.0ot2.1(cid:8)(6.0(cid:8)
*5.1(cid:7)5.1(cid:8)
3.7(cid:7)3.43
0.7(cid:7)9.53
*5.1(cid:7)1.2(cid:8)
5.7(cid:7)8.13
8.7(cid:7)9.33
)²m/gk(IMB
800.0
)7.0(cid:8)ot3.4(cid:8)(5.2(cid:8)
*7.4(cid:7)8.2(cid:8)
7.41(cid:7)5.901
9.41(cid:7)3.211
*4.4(cid:7)3.5(cid:8)
1.81(cid:7)5.501
4.81(cid:7)8.011
)mc(tsiaW
49.0
)4.1ot5.1(cid:8)(1.0(cid:8)
*9.3(cid:7)8.3(cid:8)
2.21(cid:7)5.711
7.21(cid:7)3.121
*4.3(cid:7)9.3(cid:8)
8.71(cid:7)5.411
8.71(cid:7)4.811
)mc(piH
300.0
)10.0ot30.0(cid:8)(20.0(cid:8)
40.0(cid:7)10.0
70.0(cid:7)39.0
70.0(cid:7)39.0
‡30.0(cid:7)20.0(cid:8)
70.0(cid:7)29.0
80.0(cid:7)49.0
)mc(oitarpih-ot-tsiaW
snoitacidemsetebaidesohwstnapicitraP (cid:1)n,nagev42(cid:1)n(degnahcnudeniamer
)ADA33
10.0
)91.0(cid:8)ot15.1(cid:8)(58.0(cid:8)
11.1(cid:7)83.0(cid:8)
30.1(cid:7)05.7
39.0(cid:7)88.7
†83.1(cid:7)32.1(cid:8)
48.0(cid:7)48.6
42.1(cid:7)70.8
)%(C1A
21.0
)13.0ot46.2(cid:8)(71.1(cid:8)
‡05.2(cid:7)75.1
50.2(cid:7)43.7
50.2(cid:7)09.8
†50.3(cid:7)37.2
08.1(cid:7)21.7
59.2(cid:7)58.9
)l/lomm(esoculgamsalpgnitsaF
21.0
)5.5ot6.74(cid:8)(1.12(cid:8)
‡0.54(cid:7)2.82(cid:8)
9.63(cid:7)2.231
0.73(cid:7)3.061
†0.55(cid:7)2.94(cid:8)
4.23(cid:7)2.821
2.35(cid:7)4.771
)ld/gm(esoculgamsalpgnitsaF
100.0
)4.1(cid:8)ot5.5(cid:8)(4.3(cid:8)
*4.3(cid:7)1.3(cid:8)
1.91(cid:7)9.69
4.91(cid:7)0.001
*3.4(cid:7)5.6(cid:8)
4.22(cid:7)9.59
6.32(cid:7)4.201
)gk(thgieW
100.0
)5.0(cid:8)ot9.1(cid:8)(2.1(cid:8)
*2.1(cid:7)1.1(cid:8)
9.5(cid:7)9.43
8.5(cid:7)0.63
*5.1(cid:7)3.2(cid:8)
2.7(cid:7)8.33
5.7(cid:7)1.63
)²m/gk(IMB
710.0
)5.0(cid:8)ot8.4(cid:8)(7.2(cid:8)
‡2.4(cid:7)3.2(cid:8)
5.31(cid:7)0.111
1.31(cid:7)3.311
*7.3(cid:7)0.5(cid:8)
8.71(cid:7)3.011
9.71(cid:7)3.511
)mc(tsiaW
32.0
)7.0ot7.2(cid:8)(0.1(cid:8)
*3.3(cid:7)1.3(cid:8)
6.11(cid:7)6.811
1.21(cid:7)7.121
*8.2(cid:7)1.4(cid:8)
3.71(cid:7)1.911
4.71(cid:7)3.321
)mc(piH
01.0
)00.0ot30.0(cid:8)(20.0(cid:8)
40.0(cid:7)00.0
80.0(cid:7)49.0
70.0(cid:7)39.0
30.0(cid:7)10.0(cid:8)
70.0(cid:7)39.0
80.0(cid:7)49.0
)mc(oitarpih-ot-tsiaW
elbairavlaneR
54.0
)7.11ot9.52(cid:8)(1.7(cid:8)
9.35(cid:7)3.11(cid:8)
0.212(cid:7)7.34
1.362(cid:7)0.55
‡0.93(cid:7)4.81(cid:8)
8.71(cid:7)6.41
8.15(cid:7)0.33
h42/nimublayranirU
AN
A
N
2(cid:8)6
8
7(cid:8)
5
21
)m(h42/gm03(cid:3)nimublahtiW
)ADA05(cid:1)n,nagev84(cid:1)n(erusserpdoolB
§)gHmm(
39.0
)1.5ot5.5(cid:8)(2.0(cid:8)
7.31(cid:7)6.3(cid:8)
5.61(cid:7)4.911
1.51(cid:7)9.221
(cid:1)6.21(cid:7)8.3(cid:8)
3.81(cid:7)0.021
1.71(cid:7)8.321
cilotsyS
03.0
)6.1ot2.5(cid:8)(8.1(cid:8)
(cid:1)8.8(cid:7)3.3(cid:8)
1.11(cid:7)7.67
5.01(cid:7)0.08
*3.8(cid:7)1.5(cid:8)
2.01(cid:7)8.27
1.11(cid:7)9.77
cilotsaiD
stnapicitrapllA
65.0
)3.8ot3.51(cid:8)(5.3(cid:8)
*5.03(cid:7)2.42(cid:8)
2.63(cid:7)6.471
0.44(cid:7)9.891
*5.82(cid:7)7.72(cid:8)
9.13(cid:7)3.951
4.73(cid:7)0.781
)ld/gm(loretselohclatoT
43.0
)9.1ot5.5(cid:8)(8.1(cid:8)
(cid:1)0.11(cid:7)2.3(cid:8)
8.11(cid:7)6.64
5.41(cid:7)8.94
*1.7(cid:7)0.5(cid:8)
9.61(cid:7)3.74
7.91(cid:7)3.25
)ld/gm(loretselohcLDH
87.0
)2.01ot6.31(cid:8)(7.1(cid:8)
*5.13(cid:7)0.12(cid:8)
0.53(cid:7)0.821
1.44(cid:7)0.941
*2.82(cid:7)7.22(cid:8)
9.13(cid:7)0.211
2.93(cid:7)7.431
)ld/gm(loretselohcLDH-noN
29.0
)4.0ot4.0(cid:8)(0.0(cid:8)
(cid:1)2.1(cid:7)4.0(cid:8)
2.1(cid:7)9.3
7.1(cid:7)3.4
(cid:1)9.0(cid:7)3.0(cid:8)
2.1(cid:7)7.3
6.1(cid:7)0.4
)ld/gm(LDH/loretselohclatoT
68.0
)3.01ot3.21(cid:8)(0.1(cid:8)
*1.52(cid:7)4.51(cid:8)
3.33(cid:7)1.301
5.14(cid:7)5.811
†6.03(cid:7)4.61(cid:8)
8.72(cid:7)0.88
9.23(cid:7)4.401
84(cid:1)n,nagev94(cid:1)n(loretselohcLDL
¶)ld/gm()ADA
06.0
)8.5ot4.3(cid:8)(2.1
(cid:1)4.21(cid:7)4.4(cid:8)
0.01(cid:7)3.22
8.31(cid:7)8.62
(cid:1)0.01(cid:7)2.3(cid:8)
2.01(cid:7)0.32
4.41(cid:7)2.62
74(cid:1)n,nagev74(cid:1)n(loretselohcLDLV
)ld/gm()ADA
78.0
)6.83ot2.54(cid:8)(3.3(cid:8)
7.421(cid:7)1.52(cid:8)
4.411(cid:7)9.231
1.331(cid:7)1.851
(cid:1)0.08(cid:7)5.82(cid:8)
0.65(cid:7)7.911
5.211(cid:7)1.841
)ld/gm(sedirecylgirT
16.0
)90.0ot50.0(cid:8)(20.0
(cid:1)02.0(cid:7)70.0(cid:8)
32.0(cid:7)50.2
52.0(cid:7)11.2
(cid:1)71.0(cid:7)50.0(cid:8)
12.0(cid:7)30.2
82.0(cid:7)80.2
sedirecylgirtgoL
Low-fatvegandietandtype2diabetes
1780 DIABETESCARE,VOLUME29,NUMBER8,AUGUST2006
©
thePearson’scorrelationofweightchange
with A1C change was r (cid:1) 0.51, P (cid:2)
0.0001(withinthevegangroup[n(cid:1)24],
r(cid:1)0.39,P(cid:1)0.05;withintheADAgroup
[n(cid:1)33],r(cid:1)0.49,P(cid:1)0.004).
Body weight fell 5.8 kg in the vegan
group (P (cid:2) 0.0001) and 4.3 kg in the
ADAgroup(P(cid:2)0.0001)(between-group
P(cid:1)0.082;baseline-adjustedP(cid:1)0.066).
Among medication-stable participants,
vegan participants lost 6.5 kg compared
with 3.1 kg for ADA participants (P (cid:2)
0.001;baseline-adjustedP(cid:1)0.001).
Thereductioninurinaryalbuminwas
significantinthevegangroup(P(cid:1)0.002)
butnotintheADAgroup(P(cid:1)0.14).The
unadjusted between-group difference
wasnotsignificant.However,afteradjust-
mentforbaselinevalues,theeffectofdiet
wassignificant(P(cid:1)0.013).
For the entire sample, there were no
between-group differences in lipid val-
ues.Amongthosewhoselipid-controlling
medicationsremainedconstant(80%[39
of49]ofvegangroup,82%[41of50]of
ADA group), reductions in total choles-
terolwere(cid:8)0.866mmol/l((cid:8)33.5mg/dl,
(cid:8)17.6%) for the vegan group and
(cid:8)0.491 mmol/l ((cid:8)19.0 mg/dl, (cid:8)9.7%)
fortheADAgroup(P(cid:1)0.0125).Changes
in LDL cholesterol were (cid:8)0.58 mmol/l
((cid:8)22.6 mg/dl, (cid:8)21.2%) for the vegan
groupand(cid:8)0.277mmol/l((cid:8)10.7mg/dl,
(cid:8)9.3%)fortheADAgroup(P(cid:1)0.023).
ChangesinHDLcholesterolwere(cid:8)0.16
mmol/l ((cid:8)6.0 mg/dl, (cid:8)11.0%) for the
vegan group and (cid:8)0.07 mmol/l ((cid:8)2.8
mg/dl, (cid:8)5.7%) for the ADA group (P (cid:1)
0.14).Thetotal-to-HDLcholesterolratio
fell for both groups, as did triglyceride
concentrations.
Therewerenotreatment-relatedseri-
ousadverseevents.
CONCLUSIONS— Both diets were
associated with significant clinical im-
provements,asindicatedbyreductionsin
A1C, body weight, plasma lipid concen-
trations, and urinary albumin excretion.
Among medication-stable participants,
changes in A1C, weight, BMI, waist cir-
cumference, total cholesterol, and LDL
cholesterol were significantly greater in
the vegan group. The magnitude of A1C
reduction in medication-stable vegan
group participants, 1.23 percentage
points,comparesfavorablywiththatob-
served in single-agent therapy with oral
diabetesdrugs(15).
Alow-fatplant-baseddietinfluences
nutrientintakeandbodycompositionin
several ways that may, in turn, affect in-
-dipilotsegnahconhtiwstnapicitraP
,nagev93(cid:1)n(snoitacidemgnillortnoc
)detonsatpecxe,ADA14(cid:1)n
10.0
)2.3(cid:8)ot8.52(cid:8)(5.41(cid:8)
*5.82(cid:7)0.91(cid:8)
2.63(cid:7)9.571
9.04(cid:7)9.491
*5.12(cid:7)5.33(cid:8)
1.52(cid:7)9.651
8.63(cid:7)5.091
)ld/gm(loretselohclatoT
41.0
)1.1ot5.7(cid:8)(2.3(cid:8)
6.11(cid:7)8.2(cid:8)
2.21(cid:7)4.64
5.51(cid:7)2.94
*8.6(cid:7)0.6(cid:8)
4.81(cid:7)6.84
0.12(cid:7)6.45
)ld/gm(loretselohcLDH
50.0
)3.0ot9.22(cid:8)(3.11(cid:8)
(cid:1)1.03(cid:7)3.61(cid:8)
9.53(cid:7)4.921
9.24(cid:7)7.541
*1.12(cid:7)6.72(cid:8)
6.52(cid:7)3.801
4.83(cid:7)9.531
)ld/gm(loretselohcLDH-noN
89.0
)4.0ot4.0(cid:8)(0.0(cid:8)
2.1(cid:7)3.0(cid:8)
3.1(cid:7)0.4
8.1(cid:7)4.4
‡6.0(cid:7)3.0(cid:8)
2.1(cid:7)6.3
5.1(cid:7)9.3
)ld/gm(LDH/loretselohclatoT
20.0
)7.1(cid:8)ot2.22(cid:8)(9.11(cid:8)
(cid:1)3.32(cid:7)7.01(cid:8)
7.33(cid:7)6.401
4.04(cid:7)3.511
*0.22(cid:7)6.22(cid:8)
5.22(cid:7)6.48
3.43(cid:7)3.701
93(cid:1)n,nagev93(cid:1)n(loretselohcLDL
¶)ld/gm()ADA
98.0
)6.5ot8.4(cid:8)(4.0
1.21(cid:7)8.3(cid:8)
0.9(cid:7)7.12
2.31(cid:7)5.52
(cid:1)5.01(cid:7)5.3(cid:8)
9.01(cid:7)1.32
4.51(cid:7)6.62
83,nagev(cid:1)n83(cid:1)n(loretselohcLDLV
)ld/gm()ADA
89.0
)2.74ot9.54(cid:8)(6.0
3.431(cid:7)8.22(cid:8)
9.221(cid:7)6.431
0.341(cid:7)4.751
(cid:1)5.85(cid:7)2.22(cid:8)
3.75(cid:7)2.811
1.98(cid:7)3.041
)ld/gm(sedirecylgirT
86.0
)1.0ot1.0(cid:8)(20.0
12.0(cid:7)60.0(cid:8)
42.0(cid:7)50.2
52.0(cid:7)11.2
61.0(cid:7)40.0(cid:8)
22.0(cid:7)20.2
82.0(cid:7)60.2
sedirecylgirtgoL
rof50.0(cid:2)P(cid:1)dna,10.0(cid:2)P‡,100.0(cid:2)P†,1000.0(cid:2)P*.)skeew22otenilesab(segnahc)ADA.svnagev(puorg-neewtebfosnosirapmocroferaseulavPdetsiL.detacidniesiwrehtosselnuDS(cid:7)snaemeraataD puorg-ADAowt;LDL-tceridaivdetaluclacsawLDL,ld/gm004dedeecxesedirecylgirtnehW¶.eruliaftnempiuqeoteudtnapicitrappuorgnagevenonodenimretedtonsawerusserpdoolB§.segnahcpuorg-nihtiw
.3110.0ybylpitlum,sedirecylgiyrtrof;9520.0ybylpitlum,l/lommotloretselohclatotdna,LDL,LDHtrevnocot:noisrevnocIS.selpmasamsalptneicfifusfokcaloteuddedulcxeerewslaudividni
BarnardandAssociates
DIABETESCARE,VOLUME29,NUMBER8,AUGUST2006 1781
©
Low-fatvegandietandtype2diabetes
portionscan,asaresult,easilyexceedrec-
ommendedlimitsonsaturatedfat.Incon-
trast, the vegan diet includes no animal
fat,sovariationsinfoodquantityareless
likelytoresultinsubstantialincreasesin
saturated fat intake. Because the vegan
dietisbasedontheeliminationofcertain
foods,itmaybeeasiertounderstandthan
regimens that limit quantities of certain
foods without proscribing any. The ac-
ceptabilityoflow-fatvegandietsinclini-
calstudiesissimilartothatofseemingly
moremoderatediets(27).
This study’s strengths include its
analysis of dependent measures without
regard to variations in dietary adherence
andapplicabilityoutsidetheresearchset-
ting.Astudylimitationwasthatbothdi-
ets made participants vulnerable to the
Figure1—A1Catbaselineandat11and22weeks.Opencircles:allvegangroupparticipants
hypoglycemic effect of their diabetes
(n(cid:1)49);closedcircles:medication-stablevegangroupparticipants(n(cid:1)24);opensquares:all
ADAgroupparticipants(n(cid:1)50);closedsquares:medication-stableADAgroupparticipants(n(cid:1) medications, resulting in medication re-
33).ErrorbarsrepresentSEofthemean.P(cid:1)0.09forbetween-groupcomparisonfrombaseline ductionsthatconfoundtheinterpretation
to22weeksforfullsample;P(cid:1)0.01formedication-stableparticipants(veganvs.ADA). of A1C changes and necessitating a sub-
group analysis of medication-stable par-
ticipants. Because these episodes
sulinsensitivity.First,becausesuchdiets fore diabetes manifests (20). This lipid occurred early in the trial, there was no
arelowinfatandhighinfiber,theytyp- accumulation may be responsive to diet. opportunity to bring interim laboratory
ically cause associated reductions in di- High-fatdietsappeartodownregulatethe valuesforward.Also,moststudypartici-
etary energy density and energy intake, genes required for mitochondrial oxida- pantsweretakingantihypertensivemed-
which are not fully compensated for by tive phosphorylation in skeletal muscle ications, which may have blunted the
increased food intake (16,17). Our data (21). In contrast, a case-control study effectofdietonbloodpressure.
suggestthattheweight-reducingeffectof found that soleus muscle intramyocellu- In conclusion, in individuals with
thevegandiet(4)isresponsibleforasub- larlipidconcentrationsweresignificantly type2diabetesparticipatingina22-week
stantialportionofitseffectonA1C. lowerinagroupof21veganscompared clinicaltrial,bothalow-fatvegandietand
Independent of their effect on body with25omnivores((cid:8)9.7[95%CI(cid:8)16.2 adietfollowingADAguidelinesimproved
weight,reductionsintotalfatintakeand to(cid:8)3.3],P(cid:1)0.01)(22). glycemic control; however, the changes
in the proportion of dietary saturated to Thelipid-loweringeffectofvegandi- weregreaterinthevegangroup.Further
unsaturatedfatincreaseinsulinsensitivity ets,attributabletotheirabsenceofdietary research is necessary to establish longer-
(18), as do increased intake of low– cholesterol,lowsaturatedfatcontent,and termdieteffectsandsustainability.
glycemicindexandhigh-fiberfoods(1). a specific cholesterol-reducing effect of
Finally, limited evidence suggests solublefiberandotherplantconstituents
thatreductionsinironstoresincreasein- (23), is particularly important given that Acknowledgments—The study was sup-
sulin sensitivity (19). A vegan diet pro- cardiovascularcomplicationsarethepri- ported by grant R01 DK059362-01A2 from
theNationalInstituteofDiabetesandDiges-
videsironinitsnonhemeform,whichis marycauseofmorbidityandmortalityin
tiveandKidneyDiseasesandbytheDiabetes
somewhat less absorbable than heme diabetes.Whiledietshighinrefinedcar-
ActionResearchandEducationFoundation.
iron.Astudycomparing30ovolactoveg- bohydratemayincreasetriglyceridecon-
The authors express appreciation to Paul
etariansand30meateaters,allofwhom centrations,high-fiberandlow–glycemic
Poppen,PhD,forstatisticalanalyses.
were healthy and had BMIs (cid:2)23 kg/m2, index foods appear to have the opposite
showed that vegetarians had adequate, result(24).
but lower, body iron stores, compared The limited compliance of the ADA References
with meat eaters (serum ferritin concen- groupmeritscomment.Researchershave 1. Jenkins DJA, Kendall CWC, Marchie A,
tration 35 (cid:5)g/l [95% CI 21–49] vs. 72 longlamentedthedifficultiesinadhering Jenkins AL, Augustin LSA, Ludwig DS,
(cid:5)g/l [45–100]). The vegetarians also todietsfordiabetes(25).TheA1Creduc- BarnardND,AndersonJW:Type2diabe-
demonstrated less insulin resistance tionobservedintheADAgroupwassim- tesandthevegetariandiet.AmJClinNutr
(steady-state plasma glucose concentra- ilartothatfoundinpreviousstudies(26). 78:610S–616S,2003
2. FraserGE:Vegetarianismandobesity,hy-
tion4.1mmol/l[3.5–5.0]vs.6.9mmol/l A potential weakness of the ADA guide-
pertension,diabetes,andarthritis.InDiet,
[5.2–7.5],respectively)(19). linesisthattheyrequireportionsizelim-
LifeExpectancy,andChronicDisease.Ox-
Insulin resistance is related to lipid its for overweight individuals, and
ford, U.K., Oxford University Press,
accumulation within muscle cells (in- limitations on saturated-fat intake are
2003,p.129–148
tramyocellularlipid),apparentlyduetoa basedontheselimitedenergyintakes.In- 3. NicholsonAS,SklarM,BarnardND,Gore
geneticallybasedreductioninmitochon- dividualswhoexceedtheirprescribeden- S, Sullivan R, Browning S: Toward im-
drial activity identifiable many years be- ergy intake limits with overly large proved management of NIDDM: a ran-
1782 DIABETESCARE,VOLUME29,NUMBER8,AUGUST2006
©
BarnardandAssociates
domized, controlled, pilot intervention densitylipoproteincholesterolinplasma phosphorylationinskeletalmuscle.Dia-
usingalow-fat,vegetariandiet.PrevMed withoutuseofthepreparativeultracentri- betes54:1926–1933,2005
29:87–91,1999 fuge.ClinChem18:499–502,1972 22. Goff LM, Bell JD, So PW, Dornhorst A,
4. BarnardND,ScialliAR,Turner-McGrievy 13. CorcoranRM,DurnanSM:Albuminde- Frost GS: Veganism and its relationship
G,LanouAJ,GlassJ:Theeffectsofalow- termination by a modified bromocresol with insulin resistance and intramyocel-
fat, plant-based dietary intervention on green method (Letter). Clin Chem 23: lular lipid. Eur J Clin Nutr 59:291–298,
body weight, metabolism, and insulin 765–766,1977 2005
sensitivity.AmJMed118:991–997,2005 14. Bouchard C, Tremblay A, LeBlanc C,
23. Jenkins DJ, Kendall CW, Marchie A,
5. Wilson DH, Bogacz JP, Forsythe CM, LortieG,SavardR,TheriaultG:Amethod
Faulkner DA, Wong JM, de Souza R,
TurkPJ,LaneTL,GatesRC,BrandtDR: to assess energy expenditure in children
Emam A, Parker TL, Vidgen E, Lapsley
Fully automated assay of glycohemoglo- andadults.AmJClinNutr37:461–467,
KG, Trautwein EA, Josse RG, Leiter LA,
binwiththeAbbottIMxanalyzer:novel 1983
ConnellyPW:Effectsofadietaryportfolio
approachesforseparationanddetection. 15. Krentz AJ, Bailey CJ: Oral antidiabetic
on cholesterol-lowering foods vs lova-
ClinChem39:2090–2097,1993 agents: current role in type 2 diabetes
statinonserumlipidsandC-reactivepro-
6. American Diabetes Association: Evi- mellitus (Review). Drugs 65:385–411,
dence-basednutritionprinciplesandrec- 2005 tein.JAMA290:502–510,2003
ommendations for the treatment and 16. KendallA,LevitskyDA,StruppBJ,Liss- 24. Jenkins DJ, Wolever TM, Kalmusky J,
prevention of diabetes and related com- nerL:Weightlossonalow-fatdiet:con- Guidici S, Giordano C, Patten R, Wong
plications (Position Statement). Diabetes sequenceoftheimprecisionofthecontrol GS, Bird JN, Hall M, Buckley G, et al.:
Care26(Suppl.1):S51–S61,2003 offoodintakeinhumans.AmJClinNutr Low-glycemic index diet in hyperlipid-
7. Schakel SF, Sievert YA, Buzzard IM: 53:1124–1129,1991 emia: use of traditional starchy foods.
Sourcesofdatafordevelopingandmain- 17. HowarthNC,SaltzmanE,RobertsSB:Di- AmJClinNutr46:66–71,1987
taininganutrientdatabase.JAmDietAs- etary fiber and weight regulation (Re- 25. LaitinenJH,AholaIE,SarkkinenES,Win-
soc88:1268–1271,1988 view).NutrRev59:129–139,2001 bergRL,Harmaakorpi-IivonenPA,Uus-
8. BarthelmaiW,CzokR:Enzymaticdeter- 18. Lovejoy JC, Windhauser MM, Rood JC, itupa MI: Impact of intensified dietary
minations of glucose in the blood, cere- de la Bretonne JA: Effect of a controlled therapy on energy and nutrient intakes
brospinalfluidandurine.KlinWochenschr high-fatversuslow-fatdietoninsulinsen- andfattyacidcompositionofserumlipids
40:585–589,1962[inGerman] sitivityandleptinlevelsinAfrican-Amer-
inpatientswithrecentlydiagnosednon-
9. Allain CC, Poon LS, Chan CSG, Rich- ican and Caucasian women. Metabolism
insulin-dependentdiabetesmellitus.JAm
mond W, Fu PC: Enzymatic determina- 47:1520–1524,1998
DietAssoc93:276–283,1993
tionoftotalserumcholesterol.ClinChem 19. Hua NW, Stoohs RA, Facchini FS: Low
26. Franz MJ, Splett PL, Monk A, Barry B,
20:470–475,1974 ironstatusandenhancedinsulinsensitiv-
McClainK,WeaverT,UphamP,Bergen-
10. Wieland H, Seidel D: A simple specific ityinlacto-ovovegetarians.BrJNutr86:
stal R, Mazze RS: Cost-effectiveness of
method for precipitation of low density 515–519,2001
medicalnutritiontherapyprovidedbydi-
lipoproteins. J Lipid Res 24:904–909, 20. PetersenKF,DufourS,BefroyD,Garcia
etitiansforpersonswithnon-insulin-de-
1983 R, Shulman GI: Impaired mitochondrial
11. Finley PR, Schifman RB, Williams RJ, activity in the insulin-resistant offspring pendentdiabetesmellitus.JAmDietAssoc
LichtDA:Cholesterolinhigh-densityli- of patients with type 2 diabetes. N Engl 95:1018–1024,1995
poprotein: use of Mg2(cid:10)/dextran sulfate JMed350:664–671,2004 27. BarnardND,ScialliAR,Turner-McGrievy
initsenzymaticmeasurement.ClinChem 21. Sparks LM, Xie H, Koza RA, Mynatt R, GM,LanouAJ:Acceptabilityofalow-fat
24:931–933,1978 HulverMW,BrayGA,SmithSR:Ahigh- vegandietcomparesfavorablytoastepII
12. FriedewaldWT,LevyRI,FredricksonDS: fatdietcoordinatelydownregulatesgenes diet in a randomized, controlled trial.
Estimation of the concentration of low- required for mitochondrial oxidative JCardiopulmRehabil24:229–235,2004
DIABETESCARE,VOLUME29,NUMBER8,AUGUST2006 1783
©
